Literature DB >> 16105489

Ablation of ventricular fibrillation and tachycardia.

Paveljit S Bindra1, Francis E Marchlinski.   

Abstract

Catheter ablation therapy for ventricular tachycardia has evolved over the past 20 years to become the first-line therapy. This development has been facilitated by technology that has allowed better anatomic and electrophysiologic correlations. A better understanding of radiofrequency (RF) ablation has led to safer and more effective treatments, allowing it to become a potent diagnostic and therapeutic tool in clinical cardiac electrophysiology. As more knowledge is gained about the mechanisms of arrhythmias through RF ablations, and better mapping technology and more effective methods for energy delivery become available, catheter ablation will become relevant for an increasing number of arrhythmias. This article addresses advances and applications of RF ablation to the treatment of ventricular arrhythmias in a variety of heart diseases.

Entities:  

Mesh:

Year:  2005        PMID: 16105489     DOI: 10.1007/s11886-005-0087-2

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  46 in total

1.  Catecholamine facilitated reentrant ventricular tachycardia: uncoupling of adenosine's antiadrenergic effects.

Authors:  B B Lerman; K M Stein; S M Markowitz; S Mittal; D Slotwiner
Journal:  J Cardiovasc Electrophysiol       Date:  1999-01

Review 2.  Idiopathic dilated cardiomyopathy.

Authors:  G W Dec; V Fuster
Journal:  N Engl J Med       Date:  1994-12-08       Impact factor: 91.245

Review 3.  Evaluation and management of ventricular outflow tract tachycardias.

Authors:  Christopher R Cole; Nassir F Marrouche; Andrea Natale
Journal:  Card Electrophysiol Rev       Date:  2002-12

4.  Preliminary animal and clinical experiences using an electromechanical endocardial mapping procedure to distinguish infarcted from healthy myocardium.

Authors:  R Kornowski; M K Hong; L Gepstein; S Goldstein; S Ellahham; S A Ben-Haim; M B Leon
Journal:  Circulation       Date:  1998-09-15       Impact factor: 29.690

5.  Radiofrequency ablation of sustained ventricular tachycardia related to the mitral isthmus in Chagas' disease.

Authors:  Mauricio Scanavacca; Eduardo Sosa; André d'Avila; Maria De Lourdes Higuchi
Journal:  Pacing Clin Electrophysiol       Date:  2002-03       Impact factor: 1.976

6.  Catheter ablation in patients with multiple and unstable ventricular tachycardias after myocardial infarction: short ablation lines guided by reentry circuit isthmuses and sinus rhythm mapping.

Authors:  K Soejima; M Suzuki; W H Maisel; C B Brunckhorst; E Delacretaz; L Blier; S Tung; H Khan; W G Stevenson
Journal:  Circulation       Date:  2001-08-07       Impact factor: 29.690

7.  Isthmus characteristics of reentrant ventricular tachycardia after myocardial infarction.

Authors:  Christian de Chillou; Dominique Lacroix; Didier Klug; Isabelle Magnin-Poull; Christelle Marquié; Marc Messier; Marius Andronache; Claude Kouakam; Nicolas Sadoul; Jian Chen; Etienne Aliot; Salem Kacet
Journal:  Circulation       Date:  2002-02-12       Impact factor: 29.690

8.  Radiofrequency catheter ablation of idiopathic left ventricular tachycardia guided by a Purkinje potential.

Authors:  H Nakagawa; K J Beckman; J H McClelland; X Wang; M Arruda; I Santoro; H A Hazlitt; I Abdalla; A Singh; H Gossinger
Journal:  Circulation       Date:  1993-12       Impact factor: 29.690

9.  Entrainment mapping and radiofrequency catheter ablation of ventricular tachycardia in right ventricular dysplasia.

Authors:  K E Ellison; P L Friedman; L I Ganz; W G Stevenson
Journal:  J Am Coll Cardiol       Date:  1998-09       Impact factor: 24.094

10.  Arrhythmogenic right ventricular cardiomyopathy. Dysplasia, dystrophy, or myocarditis?

Authors:  C Basso; G Thiene; D Corrado; A Angelini; A Nava; M Valente
Journal:  Circulation       Date:  1996-09-01       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.